HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,111,976 | +11.1% | 78,762 | -1.2% | 1.49% | +17.9% |
Q2 2023 | $8,198,379 | +91522.5% | 79,712 | -2.8% | 1.26% | -9.1% |
Q1 2023 | $8,948 | -5.7% | 81,987 | -1.6% | 1.39% | -8.0% |
Q4 2022 | $9,487 | -99.8% | 83,362 | -5.3% | 1.51% | +58.8% |
Q3 2022 | $5,446,000 | -20.1% | 88,002 | +2.9% | 0.95% | -12.9% |
Q2 2022 | $6,820,000 | -3.1% | 85,502 | +27.8% | 1.09% | +12.2% |
Q1 2022 | $7,039,000 | -4.7% | 66,902 | -2.4% | 0.98% | -4.0% |
Q4 2021 | $7,384,000 | -2.8% | 68,527 | -1.2% | 1.02% | -1.7% |
Q3 2021 | $7,600,000 | +15.7% | 69,377 | -1.1% | 1.03% | +20.8% |
Q2 2021 | $6,568,000 | -1.3% | 70,144 | -3.0% | 0.86% | -4.1% |
Q1 2021 | $6,657,000 | +20.5% | 72,327 | -4.2% | 0.89% | +4.3% |
Q4 2020 | $5,525,000 | -7.0% | 75,527 | -1.2% | 0.86% | -30.3% |
Q3 2020 | $5,939,000 | +39.1% | 76,452 | -0.5% | 1.23% | +17.9% |
Q2 2020 | $4,271,000 | +87.2% | 76,852 | -0.3% | 1.04% | +72.2% |
Q1 2020 | $2,282,000 | -19.5% | 77,052 | -1.7% | 0.60% | +24.0% |
Q4 2019 | $2,836,000 | +30.9% | 78,352 | -1.5% | 0.49% | +24.2% |
Q3 2019 | $2,166,000 | – | 79,552 | – | 0.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |